Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
8
NMPA:8
Drug Approvals
Mesalazine Enteric-coated Tablets
- Product Name
- 美沙拉嗪肠溶片
- Approval Number
- 国药准字H20253977
- Approval Date
- Apr 22, 2025
NMPA
Mesalazine Gastro-resistant Prolonged-release Granules
- Product Name
- 美沙拉秦肠溶缓释颗粒
- Approval Number
- 国药准字H20244970
- Approval Date
- Sep 26, 2024
NMPA
Mesalazine Enteric-coated Sustained-release Capsules
- Product Name
- 美沙拉嗪肠溶缓释胶囊
- Approval Number
- 国药准字H20244995
- Approval Date
- Sep 26, 2024
NMPA
Mesalazine Gastro-resistant Prolonged-release Granules
- Product Name
- 美沙拉秦肠溶缓释颗粒
- Approval Number
- 国药准字H20244969
- Approval Date
- Sep 26, 2024
NMPA
Acetylcysteine Effervescent Tablets
- Product Name
- 乙酰半胱氨酸泡腾片
- Approval Number
- 国药准字H20243168
- Approval Date
- Feb 6, 2024
NMPA
Clinical Trials
No trials found
News
No news found